Free Trial
NASDAQ:PAHC

Phibro Animal Health (PAHC) Stock Price, News & Analysis

$23.82
-0.36 (-1.49%)
(As of 10/23/2024 ET)

About Phibro Animal Health Stock (NASDAQ:PAHC)

Key Stats

Today's Range
$23.68
$24.55
50-Day Range
$18.01
$24.84
52-Week Range
$9.40
$25.11
Volume
124,042 shs
Average Volume
155,858 shs
Market Capitalization
$964.71 million
P/E Ratio
397.07
Dividend Yield
2.02%
Price Target
$15.00
Consensus Rating
Strong Sell

Company Overview

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
88th Percentile Overall Score

PAHC MarketRank™: 

Phibro Animal Health scored higher than 88% of companies evaluated by MarketBeat, and ranked 143rd out of 1,001 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Phibro Animal Health has received a consensus rating of Strong Sell. The company's average rating score is 1.40, and is based on no buy ratings, 2 hold ratings, and 3 sell ratings.

  • Amount of Analyst Coverage

    Phibro Animal Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Phibro Animal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Phibro Animal Health are expected to grow by 21.66% in the coming year, from $1.57 to $1.91 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Phibro Animal Health is 397.07, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 135.98.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Phibro Animal Health is 397.07, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 143.06.

  • Price to Earnings Growth Ratio

    Phibro Animal Health has a PEG Ratio of 0.59. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Phibro Animal Health has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Phibro Animal Health's valuation and earnings.
  • Percentage of Shares Shorted

    1.96% of the float of Phibro Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Phibro Animal Health has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Phibro Animal Health has recently decreased by 5.14%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Phibro Animal Health pays a meaningful dividend of 1.99%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Phibro Animal Health does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Phibro Animal Health is 800.13%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 25.13% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.

  • Read more about Phibro Animal Health's dividend.
  • Percentage of Shares Shorted

    1.96% of the float of Phibro Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Phibro Animal Health has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Phibro Animal Health has recently decreased by 5.14%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Phibro Animal Health has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Phibro Animal Health this week, compared to 2 articles on an average week.
  • Search Interest

    4 people have searched for PAHC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Phibro Animal Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,100.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    50.07% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Phibro Animal Health's insider trading history.
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Stock News Headlines

Watch this before it gets removed
If you missed it, my emergency election broadcast is now available - but will be removed soon
Barclays Remains a Sell on Phibro Animal Health (PAHC)
See More Headlines

PAHC Stock Analysis - Frequently Asked Questions

Phibro Animal Health's stock was trading at $11.58 at the beginning of the year. Since then, PAHC stock has increased by 105.7% and is now trading at $23.82.
View the best growth stocks for 2024 here
.

Phibro Animal Health Co. (NASDAQ:PAHC) issued its quarterly earnings results on Wednesday, August, 28th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.07. The business had revenue of $273.16 million for the quarter, compared to analysts' expectations of $262.44 million. Phibro Animal Health had a net margin of 0.24% and a trailing twelve-month return on equity of 18.08%.

Top institutional investors of Phibro Animal Health include Cardinal Capital Management (0.16%), SG Americas Securities LLC (0.03%), CWM LLC (0.02%) and nVerses Capital LLC (0.01%).
View institutional ownership trends
.

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Solid Power (SLDP), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), AT&T (T) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/28/2024
Ex-Dividend for 9/25 Dividend
9/04/2024
Dividend Payable
9/25/2024
Today
10/23/2024
Next Earnings (Estimated)
11/13/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PAHC
Employees
1,940
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.00
High Stock Price Target
$22.00
Low Stock Price Target
$9.00
Potential Upside/Downside
-37.0%
Consensus Rating
Strong Sell
Rating Score (0-4)
1.40
Research Coverage
5 Analysts

Profitability

Net Income
$2.42 million
Pretax Margin
1.07%

Debt

Sales & Book Value

Annual Sales
$1.02 billion
Cash Flow
$2.09 per share
Book Value
$6.34 per share

Miscellaneous

Free Float
20,223,000
Market Cap
$964.71 million
Optionable
Optionable
Beta
0.52
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:PAHC) was last updated on 10/24/2024 by MarketBeat.com Staff
From Our Partners